Ariana Pharma

Ariana Pharma Develops Innovative Clinical Data Analysis and Diagnostic Testing Solutions to Help the Healthcare Industry Better Adapt to Individual Biological Characteristics in Patient Treatment. Ariana Pharma's KEM® Technology Enables Personalized Treatment, Enhances the Efficacy and Safety of Patient Care, Reduces Risks and Drug Development Costs, and Accelerates Time-to-Market. KEM® is the Only FDA-Tested Technology That Systematically Explores Combinations of Biomarkers to Produce More Effective Biomarker Profiles for Personalized Medicine. The Company Was Founded in 2003 as a Spin-Off from the Pasteur Institute in Paris, France, and Opened a Subsidiary in the United States in 2012.